Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2023-03-01
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* is the outcome of rehabilitation with the app as good as the usual care?
* is the outcome for both types of shoulder arthroplasty similar?
* what is the usability of the app?.
Participants will
* have treatment according to the group they are allocated to
* fill in questionnaires at specific moments during the rehabilitation stage (0 - 3 months ) and at 1 year post-surgery
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of an Upper Extremity Physical Performance Test Battery in Patients After Shoulder Dislocation
NCT07115225
Multifactorial Approach Training for Anterior Shoulder Instability in Patients Undergoing Arthroscopic Bankart Repair
NCT06157229
Telerehabilitation in Shoulder Pathology
NCT07321444
Preoperative Rehabilitation and Education Program
NCT05965986
Reproducibility of Functional Shoulder Tests for the Return to Sport of Patients Operated on Previous Shoulder Instability
NCT05084703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APP-GROUP
Patients allocated in the app-group will use the app to rehabilitate.
APP
Patients allocated in the app-group will use the newly developed smartphone app te rehabilitate. 5 exercises are provided daily. Daily questionnaires will monitor exercise performance, VAS pain, household activities. Information modules will be sent at specific times.
PHYSIO-GROUP
Patients allocated in the physio-group will rehabilitate according to the usual care protocol
PHYSICAL THERAPY
Patients allocated in the physio-group will go, twice a week, to a physical therapist of their choice to rehabilitate. The physical therapist will follow the general guidelines provided by the hospital (surgeon).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
APP
Patients allocated in the app-group will use the newly developed smartphone app te rehabilitate. 5 exercises are provided daily. Daily questionnaires will monitor exercise performance, VAS pain, household activities. Information modules will be sent at specific times.
PHYSICAL THERAPY
Patients allocated in the physio-group will go, twice a week, to a physical therapist of their choice to rehabilitate. The physical therapist will follow the general guidelines provided by the hospital (surgeon).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primary total shoulder arthroplasty (anatomical and reverse)
* osteoarthritis, cuff tear arthropathy, pseudoparalysis
* return home after discharge from hospital
* no brace after surgery
* sufficient verbal and written comprehension
* hospitalization insurance
Exclusion Criteria
* arthroplasty for fracture or tumor
* neurological disease (parkinson, stroke, ...)
* no access to smartphone, tablet or internet connectivity
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexander Van Tongel, PhD
Role: PRINCIPAL_INVESTIGATOR
University Ghent, University Hospital Ghent
Ann Cools, PhD
Role: STUDY_CHAIR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghent University Hospital
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Alexander Van Tongel, MD, PHD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ONZ-2022-0357
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.